Metabolic markers tied to increased risk of depression and anxiety, study finds

United Kingdom News News

Metabolic markers tied to increased risk of depression and anxiety, study finds
United Kingdom Latest News,United Kingdom Headlines
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 43 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 71%

Comprehensive study within a large Swedish cohort links elevated glucose and triglyceride levels to an increased risk of developing depression, anxiety, and stress-related disorders, while higher HDL-C levels seem protective, suggesting a significant connection between metabolic health and psychiatric conditions.

By Vijay Kumar MalesuApr 3 2024Reviewed by Susha Cheriyedath, M.Sc. In a recent study published in the JAMA Network Open, a group of researchers determined if carbohydrate, lipid, and apolipoprotein biomarkers are linked to the future development of depression, anxiety, and stress-related disorders in a large Swedish cohort.

About the study The Swedish Apolipoprotein-Related Mortality Risk cohort, spanning from 1985 to 1996 and predominantly in the Stockholm region, includes 812,073 participants who underwent routine health screenings or were referred for laboratory testing due to health conditions. For this study, 211,200 participants over 16, free from mental disorders at baseline and with at least one biomarker measurement, were selected.

Study results In the substantial cohort of 211,200 participants, consisting of 58% males and 42% females, with the vast majority born in Sweden , the study observed notable trends over a mean follow-up period of 21 years. The participants had an average age of 42.1 years at their first blood sampling, with diagnoses of depression, anxiety, or stress-related disorders emerging at a mean age of 60.5 years.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NewsMedical /  🏆 19. in UK

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Women with high-risk HPV and metabolic syndrome have almost three times risk for mortality: StudyWomen with high-risk HPV and metabolic syndrome have almost three times risk for mortality: StudyUsing large-scale U.S. data following patients for more than a decade, York University Faculty of Health researchers found that women with both metabolic syndrome and high-risk strains of human papillomavirus (HPV) are at a 2.
Read more »

A number of teens meet criteria for metabolic, bariatric surgery: StudyA number of teens meet criteria for metabolic, bariatric surgery: StudyA large percentage of adolescents meet eligibility criteria for metabolic and bariatric surgery (MBS), according to a study published online Feb. 27 in Pediatrics.
Read more »

Worsening Metabolic Syndrome Increases Risk of Developing Cancer, Study FindsWorsening Metabolic Syndrome Increases Risk of Developing Cancer, Study FindsA new study has found that worsening metabolic syndrome increases the risk of developing cancer. The study, conducted by researchers at a medical institution, analyzed data from thousands of participants over a period of several years. The results showed a clear link between the progression of metabolic syndrome and the development of various types of cancer.
Read more »

CHOP study uncovers metabolic key to faster immune responseCHOP study uncovers metabolic key to faster immune responseResearchers from Children's Hospital of Philadelphia identified a key metabolite in cells that helps direct immune responses and explains at a single cell level why immune cells that most efficiently recognize pathogens, vaccines, or diseased cells grow and divide faster than other cells.
Read more »

Researchers discover key metabolic process responsible for rapid immune responsesResearchers discover key metabolic process responsible for rapid immune responsesResearchers from Children's Hospital of Philadelphia (CHOP) identified a key metabolite in cells that helps direct immune responses and explains at a single cell level why immune cells that most efficiently recognize pathogens, vaccines, or diseased cells grow and divide faster than other cells.
Read more »

Experts help bring first-of-its-kind drug for metabolic liver disease to the clinicExperts help bring first-of-its-kind drug for metabolic liver disease to the clinicLiver disease specialists at the University of Chicago Medicine will soon begin prescribing a first-of-its-kind drug for treating advanced metabolic dysfunction-associated steatotic liver disease (MASLD)—formerly known as nonalcoholic fatty liver disease (NAFLD).
Read more »



Render Time: 2025-02-21 12:04:45